|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-3-23
|
|
pubmed:abstractText |
To determine the safety and outcome following standard-dose ibritumomab tiuxetan followed by BEAM high-dose chemotherapy and autologous stem cell transplantation (ASCT) in patients with chemo-refractory aggressive non-Hodgkin's lymphoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0301-472X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
534-40
|
|
pubmed:meshHeading |
pubmed-meshheading:17379063-Adult,
pubmed-meshheading:17379063-Aged,
pubmed-meshheading:17379063-Antibodies, Monoclonal,
pubmed-meshheading:17379063-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17379063-Carmustine,
pubmed-meshheading:17379063-Combined Modality Therapy,
pubmed-meshheading:17379063-Cytarabine,
pubmed-meshheading:17379063-Disease-Free Survival,
pubmed-meshheading:17379063-Female,
pubmed-meshheading:17379063-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:17379063-Humans,
pubmed-meshheading:17379063-Lymphoma, Non-Hodgkin,
pubmed-meshheading:17379063-Male,
pubmed-meshheading:17379063-Melphalan,
pubmed-meshheading:17379063-Middle Aged,
pubmed-meshheading:17379063-Podophyllotoxin,
pubmed-meshheading:17379063-Salvage Therapy,
pubmed-meshheading:17379063-Stem Cell Transplantation,
pubmed-meshheading:17379063-Transplantation Conditioning,
pubmed-meshheading:17379063-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Yttrium-90-ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma.
|
|
pubmed:affiliation |
Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel. ashimoni@sheba.health.gov.il
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
